The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Webinars / 2021 / The side-effects of bad data in API development and manufacture
Discovery & Development Formulation

The side-effects of bad data in API development and manufacture

Innovation is key to delivering new drugs faster and cheaper, while tailoring them to patient needs.

01/28/2021 15:00 GMT

Sponsored By

Share


Available On-Demand

csm_TMM-webinar_main_06d02b494a.png


28 January 2021
15:00 GMT / 16:00 CET / 10:00 EST

Innovation is key to delivering new drugs faster and cheaper, while tailoring them to patient needs. Data drives this, but how do you know it’s the right data? From solubility and delivery to bioavailability and stability, the application of intelligent analytics is crucial to the success of your candidate formulation. The fundamental question every pharmaceutical scientist must ask himself is: “Considering the intended route of delivery, what do I need to know about this formulation?” Using real-life examples, our experts explain how the best – and worst – decisions in pharmaceutical development and manufacture are made, and offer their tips for success.

Webinar Learning Objective:

  • Understand the complementarity of physicochemical analytical tools.

  • Examine the full workflow for assessing the microstructure of pharmaceutical formulations.

  • Learn how to robustly assess the developability of a new drug product.

Visit Our Webinar Hub

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

More Webinars

November 29, 2021

Umicore roundtable on cross-coupling catalysis

Drug Discovery

September 28, 2021

How analytical techniques evolve and support biopharmaceutical drug development?

Drug Discovery

July 27, 2021

Tired of Manual Staining? Meet the LabSat® Research Platform

Recommended

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: